Medscape Neurology Scientific Advisory Board

Editorial Board — Medscape Neurology

Board Members

Mark J. Alberts, MD
- Hartford Hospital
  Hartford, Connecticut
Charles E. Argoff, MD
- Albany Medical College
  Albany Medical Center
  Albany, New York
Hans-Christoph Diener, MD, PhD
- University Hospital and Essen Headache Center
  Essen, Germany
Randolph W. Evans, MD
- Baylor College of Medicine
  Houston, Texas
Mark S. Freedman, MSc, MD
- University of Ottawa
  The Ottawa Hospital General Campus
  Ottawa, Ontario, Canada
Sam Gandy, MD, PhD
- Icahn School of Medicine at Mount Sinai
  Mount Sinai Hospital
  New York, NY

Richard S. Isaacson, MD
- Associate Professor, Department of Neurology
  Weill Cornell Medicine, New York, New York
Helmi L. Lutsep, MD
- Oregon Health and Science University
  VA Portland Health Care System
  Portland, Oregon
Thomas Roth, PhD
- Wayne State Medical School
  Henry Ford Hospital
  Detroit, Michigan
Stephen D. Silberstein, MD
- University of Pennsylvania
  Jefferson Headache Center
  Philadelphia, Pennsylvania
Michael J. Thorpy, MD
- Albert Einstein College of Medicine
  Montefiore Medical Center
  Bronx, New York
Andrew N. Wilner, MD
- University of Tennessee
  Memphis, Tennessee

Board Member Details

Mark J. Alberts, MD

Professor, Department of Neurology, University of Connecticut; Chief, Department of Neurology, Hartford Hospital, Hartford, Connecticut

Mark J. Alberts, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Portola; Bristol-Myers Squibb; Pfizer; Genentech; Janssen; Boehringer-Ingelheim
Serve(d) as a speaker or a member of a speakers bureau for: Portola; Bristol-Myers Squibb; Pfizer; Genentech; Janssen; Boehringer-Ingelheim
Receives royalties for: Athena Neuroscience

[ Back to Top ]

Charles E. Argoff, MD

Professor, Department of Neurology, Albany Medical College; Director, Comprehensive Pain Center and Pain Management Fellowship, Albany Medical Center, Albany, New York

Charles E. Argoff, MD, has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: Pfizer; Eli Lilly; Vertex; BDSI; Flowonix; Collegium; Kaleo; Teva; Shonoghi; Clexio
Serve(d) as a speaker or a member of a speakers bureau for: Teva; Amgen; Novartis; Eli Lilly; DSI; Scilex; Allergan; Tercera
Received research grant from: Grunenthal

[ Back to Top ]

Hans-Christoph Diener, MD, PhD

Senior Professor for Clinical Neurosciences, Department of Neurology, University Hospital Essen, University Duisburg-Essen, Institute for Medical Informatic, Biometry and Epidemiology, Hufelandstrasse, Essen, Germany

Hans-Christoph Diener, MD, PhD, has disclosed the following relevant financial relationships:
Received honoraria for participation in clinical trials, contribution to advisory boards or oral presentations from: Abbott; Achelios; Allergan; AstraZeneca; Bayer Vital; Bristol-Myers Squibb; Boehringer Ingelheim; CoAxia; Corimmun; Covidien; Daiichi-Sankyo; D-Pharm; Frensius; GlaxoSmithKline; Janssen-Cilag; Johnson & Johnson; Knoll; Eli Lilly; MSD; Medtronic; MindFrame; Neurobiological Technologies; Novartis; Novo Nordisk; Paion; Parke-Davis; Pfizer; Portola; Sanofi-Aventis; Schering-Plough; Servier; Solvay; St. Jude; Syngis; Talecris; Thrombogenics; WebMD Global; Wyeth and Yamanouchi; Received financial support for research projects from: AstraZeneca; GSK; Boehringer Ingelheim; Lundbeck; Novartis; Janssen-Cilag; Sanofi-Aventis; Syngis and Talecris
Serve(d) as editor of: Aktuelle Neurologie; Arzneimitteltherapie; Kopfschmerznews; Stroke News; Cephalalgia
Serve(d) on the editorial board for: Lancet Neurology; Stroke; European Neurology; Cerebrovascular Disorders

The Department of Neurology at the University Duisburg-Essen received research grants from: The German Research Council (DFG); German Ministry of Education and Research (BMBF); European Union; NIH; Bertelsmann Foundation; Heinz-Nixdorf Foundation

[ Back to Top ]

Randolph W. Evans, MD

Clinical Professor, Department of Neurology, Baylor College of Medicine, Houston, Texas

Randolph W. Evans, MD, has disclosed the following relevant financial relationships:
Serve(d) as a speaker or a member of a speakers bureau for: Amgen; Allergan; Biohaven
Received research grant from: Novartis; Teva Pharmaceuticals

[ Back to Top ]

Mark S. Freedman, MSc, MD

Professor, Department of Neurology, University of Ottawa and The Ottawa Hospital Research Institute; Director, Multiple Sclerosis Research Unit, The Ottawa Hospital – General Campus, Ottawa, Ontario

Mark S. Freedman, MSc, MD, has disclosed the following relevant financial relationships:
Serve(d) on the advisory board, board of directors, or other similar groups for: Actelion (Janssen/Johnson and Johnson); Alexion; Atara Biotherapeutics; BayerHealthcare; BiogenIdec; Celege; Clene Nanomedicine; GRI Bio; Hoffman La-Roche; Magenta Therapeutics; Merck Serono; MedDay; Novartis; Sanofi-Genzyme; Teva Canada Innovation
Serve(d) as a member of a speakers bureau for: Sanofi-Genzyme; EMD Senrono
Received honoraria or consultation fees for: Actelion (Janssen/Johnson and Johnson); Alexion; BiogenIdec; Celgene (BMS); EMD Inc; Sanofi-Genzyme; Hoffman La-Roche; Merck Serono; Novartis; Teva Canada Innovsation
Received research or educational grants: Sanofi-Genzyme Canada; Hoffman-La Roche; EMD Inc

[ Back to Top ]

Sam Gandy, MD, PhD

Mount Sinai Endowed Chair in Alzheimer's Disease Research, Icahn School of Medicine at Mount Sinai; Director, Mount Sinai Center for Cognitive Health, Mount Sinai Hospital, New York, NY

Sam Gandy, MD, PhD, has disclosed the following relevant financial relationships:
Founder of: Recuerdo, Inc.
Received research grant from: Constellation/Polyphenolics

[ Back to Top ]

Richard S. Isaacson, MD

Associate Professor, Assistant Dean of Faculty Development, Department of Neurology, Weill Cornell Medicine, New York, New York

Richard S. Isaacson, has disclosed no relevant financial relationships.

[ Back to Top ]

Helmi L. Lutsep, MD

Professor and Vice Chair, Department of Neurology, Oregon Health & Science University; Chief of Neurology, VA Portland Health Care System, Portland, Oregon

Helmi L. Lutsep, MD, has disclosed the following relevant financial relationships:
Serve(d) on the Steering Committee for: Axiomatic-SSP Trial; Bristol-Myers Squibbs
Serve(d) on the Physician Adivsory Board for: WaveCrest Trial; Coherex Medical

[ Back to Top ]

Thomas Roth, PhD

Professor, Department of Neurology, Albert Einstein College of Medicine; Director, Sleep-Wake Disorders Center, Montefiore Medical Center, Bronx, New York

Thomas Roth, PhD, has disclosed the following relevant financial relationships:
Received research grant from: Jazz Pharmaceuticals; Avadel Pharmaceuticals; Balance Therapeutics; Axsome Therapeutics; Takeda Pharmaceutical Company

[ Back to Top ]

Stephen D. Silberstein, MD

Professor, Department of Neurology, Thomas Jefferson University; Director, Jefferson Headache Center, Philadelphia, Pennsylvania

Stephen D. Silberstein, MD, has disclosed the following relevant financial relationships:
Received honoraria for serving as a consultant and/or advisory panel member for: Abide Therapeutics; Alder; Allergan; Amgen; Avanir; Biohaven; Cefaly; Curelator; Dr. Reddy's Laboratories;
Egalet Corporation; GlaxoSmithKline; eNeura; electroCore; Impel NeuroPharma; Eli Lilly; Medscape; Novartis; Satsuma; Supernus; Teva; Tehranica; Trigemina

[ Back to Top ]

Michael J. Thorpy, MD

Professor of Neurology, Albert Einstein College of Medicine; Director, Sleep-Wake Disorder Center, Montefiore Medical Center, Bronx, New York

Michael J. Thorpy, MD, has disclosed the following relevant financial relationships:
Received research grant from: Jazz; Avadel; Balance; Aysome

[ Back to Top ]

Andrew N. Wilner, MD

Associate Professor of Neurology, University of Tennessee Health Science Center, University of Tennessee; Staff Neurologist, Regional One Health, Memphis, Tennessee

Andrew N. Wilner, MD, has disclosed the following relevant financial relationships:
Serve(d) as Medical Advisor for: Accordant Health Services; CVS Health
Received income in an amount equal to or greater than $250 from: Stealth Biotherapeutics; CHG CompHealth

[ Back to Top ]